Next generation cannabinoids for chronic pain and opioid withdrawal syndrome – An alternative to opioid treatments and stemming the opioid crisis in Canada

The recent legalization of cannabis in Canada offers a unique opportunity to conduct fundamental research without the bureaucracy issues faced in other countries. The current state of cannabinoid-based therapies have focused their use in the treatment of cancer, pain, inflammation and opioid addiction, and suffer from unwanted side effects and lack of efficacy. Furthermore, the […]

Read More
Next generation cannabinoids for pain, inflammatory response, and cancer – Utilizing allosteric pathways in GPCRs to achieve greater specificity and bias

The recent legalization of cannabis in Canada offers a unique opportunity to conduct fundamental research without the bureaucracy issues faced in other countries. The current state of cannabinoid (CB) based therapies have focused their use in the treatment of cancer, pain, inflammation and opioid addiction, and suffer from unwanted side effects and lack of efficacy. […]

Read More